Cleared Traditional

K142038 - EUROIMMUN LYME ELISA(IgG/IgM)

K142038 is an FDA 510(k) clearance for EUROIMMUN LYME ELISA(IgG/IgM), manufactured by Euroimmun US. The device is a Class 2 Microbiology device with product code LSR cleared through the Traditional 510(k) pathway after a 280-day FDA review.

K142038 · Euroimmun US · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2015
Decision
280d
Days
Class 2
Risk

K142038 is an FDA 510(k) clearance for the EUROIMMUN LYME ELISA(IgG/IgM). Classified as Reagent, Borrelia Serological Reagent (product code LSR), Class II - Special Controls.

Submitted by Euroimmun US (Morris Plains, US). The FDA issued a Cleared decision on May 4, 2015 after a review of 280 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Euroimmun US devices

FDA 510(k) Submission Details - K142038

510(k) Number K142038 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 2014
Decision Date May 04, 2015
Days to Decision 280 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
178d slower than avg
Panel avg: 102d · This submission: 280d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LSR Device Classification - Class 2, Special Controls

Product Code LSR Reagent, Borrelia Serological Reagent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LSR Reagent, Borrelia Serological Reagent

All 97
Devices cleared under the same product code (LSR) and FDA review panel - the closest regulatory comparables to K142038.
Borrelia B31 ViraChip IgG Test Kit
K163504 · Viramed Biotech AG · Jul 2017
Lyme B. burgdorferi (IgG) MarStripe Test
K163095 · Trinity Biotech · Feb 2017
Anti-Borrelia burgdorferi US Westernblot (IgG)
K161513 · Euroimmun US · Aug 2016
VIDAS LYME IGM
K122979 · Biomerieux S.A. · Jun 2013
VIDAS LYME IGG
K122986 · Biomerieux S.A. · Mar 2013
ZEUS ELISA BORRELIA VLSE-1/PEPC10 IGG/IGM TEST SYSTEM
K113397 · Zeus Scientific, Inc. · Jul 2012